Literature DB >> 17563756

Hsp90 regulates processing of NF-kappa B2 p100 involving protection of NF-kappa B-inducing kinase (NIK) from autophagy-mediated degradation.

Guoliang Qing1, Pengrong Yan, Zhaoxia Qu, Hudan Liu, Gutian Xiao.   

Abstract

NF-kappaB-inducing kinase (NIK) is required for NF-kappaB activation based on the processing of NF-kappaB2 p100. Here we report a novel mechanism of NIK regulation involving the chaperone 90 kDa heat shock protein (Hsp90) and autophagy. Functional inhibition of Hsp90 by the anti-tumor agent geldanamycin (GA) efficiently disrupts its interaction with NIK, resulting in NIK degradation and subsequent blockage of p100 processing. Surprisingly, GA-induced NIK degradation is mediated by autophagy, but largely independent of the ubiquitin-proteasome system. Hsp90 seems to be specifically involved in the folding/stabilization of NIK protein, because GA inhibition does not affect NIK mRNA transcription and translation. Furthermore, Hsp90 is not required for NIK-mediated recruitment of the alpha subunit of IkappaB kinase to p100, a key step in induction of p100 processing. These findings define an alternative mechanism for Hsp90 client degradation and identify a novel function of autophagy in NF-kappaB regulation. These findings also suggest a new therapeutic strategy for diseases associated with p100 processing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563756     DOI: 10.1038/cr.2007.47

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  54 in total

Review 1.  Viral evasion of autophagy.

Authors:  Anthony Orvedahl; Beth Levine
Journal:  Autophagy       Date:  2007-11-13       Impact factor: 16.016

2.  Autophagosomal IkappaB alpha degradation plays a role in the long term control of tumor necrosis factor-alpha-induced nuclear factor-kappaB (NF-kappaB) activity.

Authors:  Amy Colleran; Aideen Ryan; Angela O'Gorman; Coralie Mureau; Catherine Liptrot; Peter Dockery; Howard Fearnhead; Laurence J Egan
Journal:  J Biol Chem       Date:  2011-03-31       Impact factor: 5.157

Review 3.  Autophagic action of new targeting agents in head and neck oncology.

Authors:  Hidemi Rikiishi
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

Review 4.  Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis.

Authors:  L Ouyang; Z Shi; S Zhao; F-T Wang; T-T Zhou; B Liu; J-K Bao
Journal:  Cell Prolif       Date:  2012-10-03       Impact factor: 6.831

5.  Titanium dioxide nanoparticles increase inflammatory responses in vascular endothelial cells.

Authors:  Sung Gu Han; Bradley Newsome; Bernhard Hennig
Journal:  Toxicology       Date:  2013-02-01       Impact factor: 4.221

6.  The IKK complex contributes to the induction of autophagy.

Authors:  Alfredo Criollo; Laura Senovilla; Hélène Authier; Maria Chiara Maiuri; Eugenia Morselli; Ilio Vitale; Oliver Kepp; Ezgi Tasdemir; Lorenzo Galluzzi; Shensi Shen; Maximilien Tailler; Nicolas Delahaye; Antoine Tesniere; Daniela De Stefano; Aména Ben Younes; Francis Harper; Gérard Pierron; Sergio Lavandero; Laurence Zitvogel; Alain Israel; Véronique Baud; Guido Kroemer
Journal:  EMBO J       Date:  2009-12-03       Impact factor: 11.598

7.  Targeting the alternative NF-κB pathway in pancreatic cancer: a new direction for therapy?

Authors:  Peter Storz
Journal:  Expert Rev Anticancer Ther       Date:  2013-05       Impact factor: 4.512

8.  Hsp90 as a gatekeeper of tumor angiogenesis: clinical promise and potential pitfalls.

Authors:  J E Bohonowych; U Gopal; J S Isaacs
Journal:  J Oncol       Date:  2010-06-24       Impact factor: 4.375

9.  p65/RelA modulates BECN1 transcription and autophagy.

Authors:  Tamara Copetti; Cosetta Bertoli; Emiliano Dalla; Francesca Demarchi; Claudio Schneider
Journal:  Mol Cell Biol       Date:  2009-03-16       Impact factor: 4.272

Review 10.  Eating the enemy within: autophagy in infectious diseases.

Authors:  A Orvedahl; B Levine
Journal:  Cell Death Differ       Date:  2008-09-05       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.